0JZZ Stock Chart & Stats
$4.87
-$0.10(-2.05%)
At close: 4:00 PM EDT
$4.87
-$0.10(-2.05%)
Day’s Range― - ―
52-Week Range$3.96 - $6.48
Previous CloseN/A
Volume10.81K
Average Volume (3M)15.77K
Market Cap
$2.40B
Enterprise Value$12.07K
Total Cash (Recent Filing)$396.56M
Total Debt (Recent Filing)$95.70M
Price to Earnings (P/E)―
Beta1.49
Next Earnings
Oct 22, 2026EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend Yield8.62%
Share Statistics
EPS (TTM)-0.02
Shares Outstanding597,200,000
10 Day Avg. Volume12,424
30 Day Avg. Volume15,768
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)0.65
Price to Sales (P/S)3.09
P/FCF Ratio13.02
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$5.38Price Target Upside10.37% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)0.11
Revenue Forecast (FY)$1.02B
Bulls Say, Bears Say
Bulls Say
Near‑term Maturity EliminationCompleting a refinancing that removes 2026–2027 maturities meaningfully reduces immediate rollover risk and refinancing pressure. By pushing principal out to 2032 and leaving only ~ $600M in mid‑2028, management gains time to execute deleveraging and asset sales, stabilizing liquidity and strategic optionality over the medium term.
Improved Liquidity & Covenant HeadroomNear‑term proceeds from asset sales plus the refinancing materially boost available liquidity and covenant coverage. Moving single‑bond covenant headroom toward ~200% and potentially ~300% creates structural breathing room to delever, reduces default probability, and permits time to rebuild unencumbered asset buffers and pursue capital recycling.
Post‑acute Portfolio StrengthRobust post‑acute operator performance and high EBITDARM coverage indicate more predictable rent coverage from a growing subsegment. Strong coverage ratios (post‑acute 2.4x, general acute 2.8x) and operator wins reduce tenant credit volatility and support durable rental cash flows across the portfolio as management rebalances exposure.
Bears Say
Elevated LeverageLeverage at ~2.1x equity and materially reduced equity limits capital flexibility and magnifies downside from tenant stress or asset‑value declines. High leverage constrains strategic options, increases covenant sensitivity, and means future capital needs will be more reliant on successful asset sales or costly external financing.
Higher‑cost Secured Financing & Secured‑debt ConcentrationIssuance of relatively high‑coupon secured debt raises interest expense and materially increases secured‑debt concentration versus unsecured paper. Approaching secured‑debt covenant thresholds reduces capacity for additional secured borrowing and forces reliance on asset sales or expensive funding, raising structural refinancing and cash‑flow pressure.
Tenant Cash‑collection & Behavioral HeadwindsPartial rent payments, EMR conversion disruptions at HSA and phased NOR recoveries, together with weak behavioral coverage, reduce predictability of rental cash flow and increase volatility in NFFO. Persistent operator operational problems can force additional working‑capital support or concessions, pressuring covenants and limiting sustainable cash available for deleveraging.
Medical Properties Trust News
0JZZ FAQ
What was Medical Properties Trust’s price range in the past 12 months?
Medical Properties Trust lowest share price was $3.96 and its highest was $6.48 in the past 12 months.
What is Medical Properties Trust’s market cap?
Medical Properties Trust’s market cap is $2.40B.
When is Medical Properties Trust’s upcoming earnings report date?
Medical Properties Trust’s upcoming earnings report date is Oct 22, 2026 which is in 69 days.
How were Medical Properties Trust’s earnings last quarter?
Medical Properties Trust released its earnings results on Aug 10, 2026. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of $0.007 by -$0.017.
Is Medical Properties Trust overvalued?
According to Wall Street analysts Medical Properties Trust’s price is currently Undervalued.
Does Medical Properties Trust pay dividends?
Medical Properties Trust pays a Quarterly dividend of $0.09 which represents an annual dividend yield of 8.62%. See more information on Medical Properties Trust dividends here
What is Medical Properties Trust’s EPS estimate?
Medical Properties Trust’s EPS estimate is 0.01.
How many shares outstanding does Medical Properties Trust have?
Medical Properties Trust has 597,200,000 shares outstanding.
What happened to Medical Properties Trust’s price movement after its last earnings report?
Medical Properties Trust reported an EPS of -$0.01 in its last earnings report, missing expectations of $0.007. Following the earnings report the stock price went down -11.563%.
Which hedge fund is a major shareholder of Medical Properties Trust?
Currently, no hedge funds are holding shares in GB:0JZZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medical Properties Trust Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.38 (10.37% Upside)
$5.38 (10.37% Upside)
Blogger Sentiment
Bullish
GB:0JZZ Sentiment 69%
Sector Average 56%
Sector Average 56%
News Sentiment
Very Bullish
Bullish news 80%
Bearish news 20%
Bearish news 20%
Technicals
SMA
Negative
20 days / 200 days
Momentum
20.90%
12-Months-Change
Fundamentals
Return on Equity
8.62%
Trailing 12-Months
Asset Growth
-2.66%
Trailing 12-Months
Company Description
Medical Properties Trust
Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements. Its extensive property holdings encompass a diverse array of medical establishments, such as rehabilitation centers, extended-stay acute care hospitals, outpatient surgical facilities, hospitals catering to women and children, community and regional general hospitals, medical office complexes, and various other specialized care sites. The trust was established in 2003 by its co-founders, Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie, with its principal offices situated in Birmingham, Alabama.
0JZZ Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call contained several material positives: a comprehensive refinancing that removes near-term maturities, expected near-term liquidity (~$1.1B) and strong asset-sale realizations that validate portfolio values, plus robust post-acute performance and stable normalized FFO. Offsetting risks include behavioral segment weakness (particularly in the UK), operational cash-collection issues at HSA and phased rent recoveries (NOR), higher G&A/impairments, and the issuance of relatively costly secured debt (9.25%) that raises the secured-debt ratio close to covenant thresholds. On balance, management has cleared immediate maturity risk and highlighted multiple paths to further delevering, while acknowledging near-term operational and cash-collection challenges.View all GB:0JZZ earnings summaries0JZZ Stock 12 Month Forecast
Average Price Target
$5.38
▲(10.37% Upside)
Technical Analysis
LTC Properties
―
National Health Investors
―
Sabra Healthcare REIT
―
Diversified Healthcare Trust
―
CareTrust REIT
―